α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.

J Cell Mol Med · 2020 · PMC6933365 · PMID 31762191

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In addition, IHC of tumour samples revealed an increasing trend of FASN expression in the gemcitabine treatment group, while FASN expression was repressed in the α‐mangostin and gemcitabine combination treatment group.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.